• Open Account

Jenburkt Pharmaceuticals Ltd

Small Cap  | Pharmaceuticals
₹ 947.1 -7.1(-0.74%)
Last updated: 01-Jan-1980 , 00:00:00
Jenburkt Pharmaceuticals Ltd Price Today Jenburkt Pharmaceuticals Ltd share price is ₹947.1 as on 01-Jan-1980, Down 0.74% from the previous close of ₹954.2. The stock has traded between ₹963 and ₹944.25 today, against a 52-week range of ₹N/A to ₹N/A. Over the past year the stock is N/A range. Market capitalisation stands at ₹393.71 crore.

Jenburkt Pharmaceuticals Ltd Live Price Chart

Performance

Low: ₹944.25 High: 963
Previous Close ₹ 954.2
High ₹ 963
Volume 924
52W Range ₹ - ₹
Open ₹ 963
Low ₹ 944.25
Market Cap ₹ 393.71 Cr

Jenburkt Pharmaceuticals Ltd Technicals

Current Price
₹ 947.1 -7.1 (-0.74%)
EMASMA
20 Day ₹ 954.233
50 Day ₹ 1,002.439
100 Day ₹ 1,038.602
200 Day ₹ 1,066.530
20 Day ₹ 955.420
50 Day ₹ 1,018.346
100 Day ₹ 1,071.942
200 Day ₹ 1,065.494

Jenburkt Pharmaceuticals Ltd Fundamentals

ROCE 23.196
P/E Ratio 12.700
P/B Ratio 2.120
Industry P/E 2.120
Debt to Equity 49.304
ROE 17.629
EPS 74.390
Dividend Yield 2.190
Book Value 446.469
Face Value 10.000

Jenburkt Pharmaceuticals Ltd Financials

Particulars Y202603 Y202503 Y202403 Y202303 Y202203
Total Revenue 179.0401 158.4125 146.6334 141.8724 128.9291
Total Expenses 128.5701 114.4797 111.4575 109.0077 99.0582
Profit After Tax 34.736 32.0606 25.9773 24.607 22.2972

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings 46.619 %
FIIs 0.000 %
DIIs 0.121 %
MutualFund 0.000 %
Retail 41.054 %
Others - 12.205 %

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family during the period 1986. The Company engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. It works more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation serve to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23. Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year. FY 2026 saw genuine distinction while the Company launched Cartisafe Forte, India's first fixed-dose combination of Undenatured Type II Collagen (40 mg), Glucosa ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals ₹ 40.59
+0.32 (+0.79%)
Amrutanjan Health Care Ltd Pharmaceuticals ₹ 508.90
+5.85 (+1.16%)
Astrazeneca Pharma India Ltd Pharmaceuticals ₹ 5,837.00
+117.5 (+2.05%)
Bliss GVS Pharma Ltd Pharmaceuticals ₹ 655.95
-11.75 (-1.76%)
Abbott India Ltd Pharmaceuticals ₹ 26,000.00
+420 (+1.64%)
Cipla Ltd Pharmaceuticals ₹ 1,301.00
-5.8 (-0.44%)

FAQs on Jenburkt Pharmaceuticals Ltd

1. Can I buy Jenburkt Pharmaceuticals Ltd from PL Capital? ›

Yes, you can invest in Jenburkt Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Jenburkt Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Jenburkt Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Jenburkt Pharmaceuticals Ltd pay dividends? ›

Yes, Jenburkt Pharmaceuticals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Jenburkt Pharmaceuticals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Jenburkt Pharmaceuticals Ltd ? ›

As of 01-Jan-1980 , 00:00:00 the share price for Jenburkt Pharmaceuticals Ltd. is ₹ 947.1 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Jenburkt Pharmaceuticals Ltd ? ›

The 52-week high and low of Jenburkt Pharmaceuticals Ltd share price is ₹ - ₹ as of 01-Jan-1980 , 00:00:00 .

5. What is the market capitalisation of Jenburkt Pharmaceuticals Ltd? ›

Market capitalisation of Jenburkt Pharmaceuticals Ltd is ₹393.71Cr as of 01-Jan-1980.

6. What is the current P/E ratio of Jenburkt Pharmaceuticals Ltd? ›

The P/E (price-to-earnings) ratio of Jenburkt Pharmaceuticals Ltd is 12.700.

7. What is the current P/B ratio of Jenburkt Pharmaceuticals Ltd? ›

The P/B (price-to-book) ratio of Jenburkt Pharmaceuticals Ltd is 2.120.

8. What is the shareholding pattern of Jenburkt Pharmaceuticals Ltd? ›

As of 01-Jan-1980, promoters hold 46.619%, foreign institutional investors hold 0.000%, domestic institutional investors hold 0.121%, and the public holds 41.054%.

9. What is the 1-year return of Jenburkt Pharmaceuticals Ltd? ›

The 1-year return of Jenburkt Pharmaceuticals Ltd is N/A range.
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Jenburkt Pharmaceuticals Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×
I consent to receive calls/messages from PL